SO4^2—／ZrO2的相结构和超强酸性及其对丁烷异构化反应的催化活性

通过沉淀、回流和掺杂等方法制备了ZrO2呈四方相及单斜相的SO4^2-／ZrO2（SZ），并用XRD，TEM，低温N2－BET和吡啶吸附IR等技术定量测量地测定和探讨了SZ的结构特征和表面超强酸性及其对丁烷异构化反应的催化活性，结果表明，ZrO2呈单斜相结构的SZ表面Broensted（B）酸与Lewis（L）酸的浓度比[B]/[L]较ZrO2以四方相为主的SZ高约40％，但其对丁烷异构化反应的比催化活性则较后者低约31％，由掺Mg^2 所制备的ZrO2呈四方相的SMZ具有与ZrO2呈纯单斜相的SZ非常接近的[B]/[L]比，且表现出比末掺Mg^2 的ZrO2以四方相为主的SZ更高的比催化活性，从催化剂晶结构对表面B酸浓度及强度影响的角度进行了讨论。     

镓掺杂SO2－4／ZrO2的制备及其对正丁烷异构化反应的催化性能

 通过沉淀、回流和浸渍法制备了镓掺杂的纳米级固体超强酸SO2－4／Ga2O3／ZrO2，并用X射线衍射、透射电镜、热重、吡啶吸附红外光谱、低温N2－BET及化学分析等技术对SO2－4／Ga2O3／ZrO2的结构、表面性质及其对正丁烷异构化反应的催化活性进行了研究．结果表明，掺杂Ga2O3可以抑制制备过程中ZrO2晶粒长大，有利于抑制高温下催化剂由四方相转变为单斜相．与未掺杂的催化剂相比，Ga2O3的掺杂提高了催化剂表面SO2－4的分解温度，有利于催化剂表面形成更多的酸中心．SO2－4／Ga2O3／ZrO2对正丁烷异构化反应显示出优异的催化性能．其中，含3％Ga2O3的样品的活性最高，220℃下其初活性为59．1％；反应1h后，其活性基本保持稳定，稳态转化率大于51％，接近该反应条件下正丁烷的平衡转化率．     

硫酸化剂和制备方法对锆基固体酸催化剂的结构和性能的影响

采用沉淀法制备ZrO2氧化物,用氯磺酸和硫酸对其进行改性制备了Zr基固体酸催化剂,以XRD、BET和NH3-FTIR等手段考察了制备条件对催化剂晶相结构和表面性质的影响,研究了催化剂结构与其对棕榈油酯化反应的催化活性之间的关系.NH3-FTIR表明催化剂表面有B酸和L酸中心的生成.硫酸化剂的种类及其引入顺序都将影响催化剂的晶相结构和孔结构.酸的引入将阻止ZrO2·nH2O在焙烧时直接向单斜相ZrO2转变,氯磺酸将使ZrO2·nH2O转变为四方相ZrO2,而硫酸将导致四方相ZrO2和Zr(SO4)2·5H2O的生成.以氯磺酸改性的四方相和单斜相ZrO2基催化剂均具有很高的催化酯化活性,比硫酸改性的S-Z固体酸催化活性高.CS-ZrO2固体酸催化活性最高,在醇油比6:1、催化剂用量7 wt%、温度338 K和常压下反应2 h,棕榈油的酯化率可达98.9%.     

镓掺杂SO4^2—／ZrO2的制备及其对正丁烷异构化反应的催化性能

通过沉淀、回流和浸渍法制备了镓掺杂的纳米级固体超强酸SO4^2-／Ga2O3／ZrO2，并用X射线衍射、透射电镜、热重、吡啶吸附红外光谱、低温N2-BET及化学分析等技术对SO4^2-／Ga2O3／ZrO2的结构、表面性质及其对正丁烷异构化反应的催化活性进行了研究．结果表明，掺杂Ga2O3可以抑制制备过程中ZrO2晶粒长大，有利于抑制高温下催化剂由四方相转变为单斜相．与未掺杂的催化剂相比，Ga2O3的掺杂提高了催化剂表面SO4^2-的分解温度，有利于催化剂表面形成更多的酸中心．SO4^2-／Ga2O3／ZrO2对正丁烷异构化反应显示出优异的催化性能．其中，含3％Ga2O3的样品的活性最高，220℃下其初活性为59．1％；反应1h后，其活性基本保持稳定，稳态转化率大于51％，接近该反应条件下正丁烷的平衡转化率．     

ZrO2前体的制备方法对WOX-/ZrO2

考察了ZrO2前体的制备方法对WOX-/ZrO2的性质及其正庚烷临氢异构化反应性能的影响,同时采用BET、XRD、Py-IR等手段对其进行了表征.结果表明,ZrO2前体的制备方法会明显影响ZrO2前体的比表面积及WOX-/ZrO2催化剂中四方ZrO2和单斜ZrO2晶型的比例,同时WO3的分散程度也有差异.单斜ZrO2太多及WO3晶型的出现会降低正庚烷临氢异构化反应活性;而ZrO2全部为四方晶型时,虽然有利于提高低温反应活性,但缺点是裂解选择性太高;而当单斜ZrO2和四方ZrO2共存,但以四方ZrO2为主,且没有WO3晶型出现时,既可保持较高的反应活性,同时又具有极高的异构化选择性.     

Al助剂对超强酸WOx/ZrO2机械应力稳定性的改善

载体ZrO2以四方相(t相)结构存在是WOx/ZrO2形成超强酸结构和高催化活性的必要条件.研究表明,机械处理(研磨和压片)可导致WOx/ZrO2的载体发生四方相向单斜相的部分转变,从而降低Pt/WOx/ZrO2的正庚烷异构化活性.添加Al助剂明显提高了载体四方相结构对机械应力的稳定性,从而维持了其催化活性.     

Al2O3／WO3／ZrO2固体强酸催化剂对正丁烷异构化的催化性能

 通过沉淀、回流、浸渍和焙烧等步骤制备了Al2O3／WO3／ZrO2固体强酸催化剂．采用XRD，N2吸附，UV－Vis光谱，NH3－TPD和H2－TPR等技术测定了Al2O3对WO3／ZrO2催化剂的结构、表面酸性、氧化还原性及正丁烷异构化反应性能的影响．结果表明，在WO3／ZrO2中引入适量的Al2O3对其表面酸强度及酸量无显著影响，但可使催化剂中的ZrO2组分以稳定的四方相形式存在，并能有效地抑制催化剂中WO3的聚集长大，从而提高催化剂的稳定性和正丁烷异构化的转化率和选择性．添加铂于Al2O3／WO3／ZrO2中可进一步提高其催化性能．还考察了催化剂的焙烧温度、Al含量、反应温度和反应气氛对正丁烷异构化反应的影响．     

纳米晶ZrO2:Sm3+的制备与发光性质研究

用化学共沉淀法制备了Sm3 掺杂浓度不同、煅烧温度不同的纳米晶ZrO2:Sm3 系列发光粉体,所制备的粉体均具有Sm3 离子特征强室温荧光发射.通过XRD分析发现:经600℃煅烧2 h后制备的纳米晶ZrO2:Sm3 是四方相结构;经800℃煅烧2 h得到的样品,以四方相为主,有少量单斜相;经950℃煅烧2 h后得到的样品,以单斜相为主,四方相的比例较小.不同煅烧温度下样品发光性质研究表明:因经不同温度煅烧制备的样品所处晶体场环境不同,发光中心也不同,经800和950℃煅烧的样品中稀土离子占据两种不同的格位,其一为四方相格位,其二是单斜相格位;ZrO2基质与Sm3 之间有能量传递,单斜相结构更有利于能量传递.荧光强度与掺Sm3 浓度关系研究表明:荧光强度先随Sm3 浓度提高而增强,在浓度达0.7%(摩尔分数)时达到最大,然后又随之降低.     

固体强酸催化剂Pd/WO3-ZrO2的制备及其对正庚烷异构化反应的催化性能

 采用共沉淀方法制备了固体酸载体WO3-ZrO2,考察了W含量和焙烧温度等对WO3-ZrO2酸性和物相结构的影响,并且考察了Pd/WO3-ZrO2催化剂对正庚烷异构化反应的催化性能. 结果表明,Pd/WO3-ZrO2催化剂的催化性能与固体强酸的W含量及晶相结构密切相关. 在w(W)=13.2%～15.8%时,经700～800 ℃焙烧,WO3在ZrO2表面达到单层分散,且大部分ZrO2以四方晶相存在,所制备的0.5%Pd/WO3-ZrO2对正庚烷异构化反应的催化活性可达到70.4%,选择性可达到81.0%.     

Ga_2O_3对Pt/WO_3/ZrO_2催化剂上正庚烷异构化反应的促进作用

考察了Ga2O3掺杂的Pt/WO3/ZrO2(Pt/WGZ)催化剂在200℃时正庚烷临氢异构化反应性能.结果表明,少量Ga2O3的加入能显著提高Pt/WGZ的催化活性,异构化选择性也有所增加,这是由于B酸位增加和B酸/L酸比的改变而引起的.Pt/WGZ催化剂连续反应80 h,正庚烷转化率和异构化选择性分别稳定在76%和94%.     

Homopolymerization of 2-alkyl- and 2-aryl-2-oxazolines

2-Aryl- and 2-alkyl-2-oxazolines have been polymerized to poly-(N-aroyl)aziridines and poly(N-acyl)aziridines, respectively, in the presence of boron trifluoride. The polymers obtained were glassy, light yellow resins with molecular weights ranging from 3500 to 7500 (35–50 oxazoline units per chain). The polymerization rates have been determined for several of these monomers. A polymerization mechanism is proposed.     

Structure and properties of single crystalline CaMg2Bi2, EuMg2Bi2, and YbMg2Bi2

Single crystals of CaMg(2)Bi(2), EuMg(2)Bi(2), and YbMg(2)Bi(2) were obtained from a Mg-Bi flux cooled to 650 °C. These materials crystallize in the CaAl(2)Si(2) structure-type (P ?3m1, No. 164), and crystal structures are reported from refinements of single crystal and powder X-ray diffraction data. EuMg(2)Bi(2) displays an antiferromagnetic transition near 7 K, which is observed via electrical resistivity, magnetization, and specific heat capacity measurements. Magnetization measurements on YbMg(2)Bi(2) reveal a weak diamagnetic moment consistent with divalent Yb. Despite charge-balanced empirical formulas, all three compounds are p-type conductors with Hall carrier concentrations of 2.0(3) × 10(19) cm(-3) for CaMg(2)Bi(2), 1.7(1) × 10(19) cm(-3) for EuMg(2)Bi(2), and 4.6(7) × 10(19) cm(-3) for YbMg(2)Bi(2), which are independent of temperature to 5 K. The electrical resistivity decreases with decreasing temperature and the resistivity ratios ρ(300 K)/ρ(10 K) ≤ 1.6 in all cases, indicating significant defect scattering.     

Synthesis and reactions of 2-chloro- and 2-tosyloxy-2'-deoxyinosine derivatives

Convenient syntheses of 2-chloro- and 2-tosyloxy-2'-deoxyinosine as their tert-butyldimethylsilyl ethers are described. Both compounds can be synthesized via a common route and rely on commercially available 2'-deoxyguanosine. The present method leading to the chloro nucleoside is operationally simpler compared to previously reported glycosylation techniques where isomeric products were obtained. Both electrophilic nucleosides can be used for the preparation of N-substituted 2'-deoxyguanosine analogues via displacement of the leaving groups, and a comparison of their reactivities shows the chloro analogue to be superior. Interestingly, a Pd catalyst-mediated, two-step, one-pot conversion of an allyl-protected chloro nucleoside intermediate to the final modified 2'-deoxyguanosine derivatives is also feasible. On the basis of these observations, initial assessments of Pd-catalyzed aryl amination as well as a C-C cross-coupling have also been performed with the chloro and tosyloxy nucleoside substrates. Results indicate a potentially high synthetic utility of 2-chloro-2'-deoxyinosine and in many instances this derivative can supplant the bromo and fluoro analogues that are more cumbersome to prepare or are not readily available.     

Synthesis of 2-deamino- and 2-deamino-2-nitroactinomycin D

A single step synthesis of 2-deaminoactinomycin D ( 3a ) and 2-deamino-2-nitroactinomycin D ( 2a ) arising from actinomycin D ( 1a, AMD ) is reported. Structural confirmation was made by nmr, ir and chemical conversion to known materials.     

Synthesis of fluorodinitromethane and 2-fluoro-2, 2-dinitroethanol

Conclusions The authors have obtained fluorodinitromethane and 2-fluoro-2, 2-dinitroethanol and studied some of their physiocochemical properties.Translated from Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya, No. 4, pp. 912–914, April, 1968.     

Sc2MgGa2 and Y2MgGa2

Scandium magnesium gallide, Sc₂MgGa₂, and yttrium magnesium gallide, Y₂MgGa₂, were synthesized from the corresponding elements by heating under an argon atmosphere in an induction furnace. These intermetallic compounds crystallize in the tetragonal Mo₂FeB₂‐type structure. All three crystallographically unique atoms occupy special positions and the site symmetries of (Sc/Y, Ga) and Mg are m2m and 4/m, respectively. The coordinations around Sc/Y, Mg and Ga are pentagonal (Sc/Y), tetragonal (Mg) and triangular (Ga) prisms, with four (Mg) or three (Ga) additional capping atoms leading to the coordination numbers [10], [8+4] and [6+3], respectively. The crystal structure of Sc₂MgGa₂ was determined from single‐crystal diffraction intensities and the isostructural Y₂MgGa₂ was identified from powder diffraction data.     

Reactions of 2-amino- and 2-hydrazinobenzimidazoles with 2-acyldimedones

The reaction of 2 formyldimedone with 2-amino- and 2-hydrazinobenzimidazoles at 20°C in ethanol gave 2-(2-benzimidazolyl)aminomethylene- and 2-[2-(2-benzimidazolyl)hydrazinomethylene]-5,5-dimethylcylohex-anediones, while this reaction carried out in ethanol at reflux in the presence of acid gave 2,2-dimethyl-4-oxo 1, 2, 3, 4-tetrahydroquinazolino(1, 2-a]benzimidazole and 1-(2-benzimidazolyl)-6, 6-dimethyl-4-oxo-4, S, 6, 7-tetrahydroindazole, respectively.Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 2, pp. 247–252, February, 1996.